advertisement
Zhang Q 22
Showing records 1 to 22 | Display all abstracts from Zhang Q109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Zhao WJ
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Massenzio E
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109412 Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects
Li Z
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 2927-2934
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Fan CL
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Xu D
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109412 Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects
Fan N
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 2927-2934
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Hu XM
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Abishek R
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109412 Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects
Cheng Y; Xiang F
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 2927-2934
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Ban XX
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Wibbelsman TD
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Wan H
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Sheng Y
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109412 Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects
Pan X; Cao K
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 2927-2934
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
He Y
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Obeid A; Bhatt S
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Zhang Q
Cellular and molecular neurobiology 2023; 43: 3161-3178
109412 Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects
Zhang Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 2927-2934
109627 Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials
Xiong K
Cellular and molecular neurobiology 2023; 43: 3161-3178
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Zhang Q
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159
109412 Factors associated with severe corneal endothelial damage following acute primary angle closure in Chinese subjects
Zhang Q; Li S
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 2927-2934
109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Sharpe J; Sharpe J; Park CH; Spirn MJ; Gupta OP; Chiang A; Shukla A; Shalaby WS; Shalaby WS; Shalaby WS; Myers JS; Hsu J
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159